HITIQ Limited (ASX: HIQ) is pleased to announce it has completed an oversubscribed placement to new and existing sophisticated investors, raising approximately $925,000 before costs through the issue of 42,045,455 ordinary shares at $0.022 per share. The placement price represents a 12.0% discount to the closing price on 1 December 2025 and an 11.9% discount to the 30-day VWAP, and includes one attaching listed option (exercisable at $0.022 and expiring 30 December 2028) for every two shares subscribed. The placement was scaled to fit within the Company’s ASX Listing Rule 7.1 capacity and is on the same terms as the rights issue completed earlier in 2025.

Funds raised will be deployed towards ongoing development and commercialisation of HITIQ’s concussion management technology, as well as general working capital. HITIQ Chairman Earl Eddings said the oversubscribed placement and support from both new and existing sophisticated investors reflects growing confidence in the Company’s strategy and the momentum in commercialising its technology. SP Corporate Advisory Pty Ltd acted as Lead Manager to the placement.